Skip to content

Silo Pharma, Inc.

SILO

CIK 0001514183 · Pharmaceutical Preparations · Nasdaq

  • Uppercut Brands, Inc. (until 2020-08-14)
  • Point Capital, Inc. (until 2019-05-14)
  • Gold Swap Inc (until 2013-01-07)
← back to feed
Revenue (TTM)
$72.1K
0.0% YoY Q1 May 2026
Net Income (TTM)
−$4.99M
+3.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.66
+58.0% YoY Q1 May 2026
Gross Margin
38.6%
Q1 May 2026
Operating Margin
-7,057.8%
Q1 May 2026
Net Margin
-6,925.3%
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$3.9M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
16.27M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings